findmyKOL
Clinical trialNCT05903404UnknownObservational

PCOS Indirect and Intangible Economic Burden

SponsorPCOS Challenge: The National Polycystic Ovary Syndrome AssociationEnrollment1,000Polycystic Ovary Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary purpose of the PCOS Indirect and Intangible Economic Buren study is to estimate the economic costs of having PCOS in terms of quality of life and work productivity. The population will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS. This study is a sub-study of The PCOS Challenge Study.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Ricardo Azziz, MD, MPH, MBA

    The University of Alabama at Birmingham

    Principal Investigator
    clinicaltrials.gov ↗
  • Sasha Ottey, MHA, MT (ASCP)

    PCOS Challenge: The National Polycystic Ovary Syndrome Association

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Pcos Challenge: the National Polycystic Ovary Syndrome Association

    Bethesda, Maryland, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jun 2022
Primary completion
30 Jun 2024
Completion
31 Dec 2024
Last update posted
15 Jun 2023
Registered enrollment
1,000
Registry id
NCT05903404
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.